U.S., Dec. 24 -- ClinicalTrials.gov registry received information related to the study (NCT07299279) titled 'Movement Improves Brain Health and Cognition in Parkinson's Disease' on May 14.
Brief Summary: Cognitive impairment is an acknowledged feature of Parkinson's disease (PD) and often coexists with the classic motor symptoms since their onset. Cognitive symptoms of PD can be differentiated from other neurodegenerative diseases by the affected domains: typically, the executive functions are primarily affected, to a greater extent than the mnesic ones. PD-MCI is of utmost clinical relevance, as it impacts the patients' quality of life and as the major predictor for conversion to PDD. To date, there are no routinely recommended interventi...